Einzig Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 13-12-2024
- Paid Up Capital ₹ 0.50 M
as on 13-12-2024
- Company Age 10 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -6.98%
(FY 2017)
- Profit 9.44%
(FY 2017)
- Ebitda -69.60%
(FY 2017)
- Net Worth 4.04%
(FY 2017)
- Total Assets 69.27%
(FY 2017)
About Einzig Pharmaceutical
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Naushad Ahmed and Syed Ahmad serve as directors at the Company.
- CIN/LLPIN
U33100DL2014PTC268387
- Company No.
268387
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jun 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Einzig Pharmaceutical?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naushad Ahmed  | Director | 27-Jun-2014 | Current |
| Syed Ahmad | Director | 27-Jun-2014 | Current |
Financial Performance of Einzig Pharmaceutical.
Einzig Pharmaceutical Private Limited, for the financial year ended 2017, experienced Minor drop in revenue, with a 6.98% decrease. The company also saw a slight improvement in profitability, with a 9.44% increase in profit. The company's net worth moved up by a moderate rise of 4.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Einzig Pharmaceutical?
In 2017, Einzig Pharmaceutical had a promoter holding of 55.00% and a public holding of 45.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Einzig Pharmaceutical?
Unlock and access historical data on people associated with Einzig Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Einzig Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Einzig Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
